Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by - Université de Rennes Access content directly
Journal Articles Journal of Clinical Endocrinology and Metabolism Year : 2016

Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by

Abstract

Scarabin PY, et meta-analysis by Mohammed et al (1) confirms the safety advantage of transdermal vs oral estrogens with respect to the risk of venous thromboembolism (VTE). Surprisingly, the quality of evidence is described as very low (see Table 4 in the report). We believe that this quality rating based on “the observational nature of the studies and inconsistency of results” is not appropriate...

Dates and versions

hal-01274220 , version 1 (15-02-2016)

Identifiers

Cite

Pierre-Yves Scarabin, Marianne Canonico, Valérie Scarabin-Carré, Emmanuel Oger. Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by. Journal of Clinical Endocrinology and Metabolism, 2016, 101 (2), pp.L30--31. ⟨10.1210/jc.2015-4248⟩. ⟨hal-01274220⟩
146 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More